Please register here if you wish to receive the most recent investor relations information about BRAIN Biotech AG via email. By registering, you give your consent that your e-mail address and, if you voluntarily choose an optional category, also this information may be saved by BRAIN Biotech AG and used accordingly.
To receive the IR newsletter, you need to provide your name and e-mail address. Before we send the first newsletter, you must explicitly confirm by the double opt-in process that we should activate the newsletter service for you. After entering your data and requesting to receive the IT Newsletter, you will therefore receive a confirmation and authorisation email asking you to click on the link contained in the email and thereby confirm that you would like to receive the IR Newsletter. You can cancel your request to receive the IR Newsletter at any time by using the “unsubscribe” link that you will find in each IR Newsletter. The data you provide (email address, name and voluntary statements) will only be used to send the IR Newsletter and to evaluate its use. The IR Newsletter is sent and its use evaluated by means of the EQS manager (EQS Group AG, Munich, Germany). This requires the storage of your data within the tool. Your data will not be made available to EQS or other third parties for their own use.